![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Juvaris BioTherapeutics Starts Early Test of Flu Vaccine Enhancement
Juvaris BioTherapeutics Starts Early Test of Flu Vaccine Enhancement
May 29, 2008
Juvaris BioTherapeutics Inc. started an early stage clinical trial of a treatment meant to enhance the effects of influenza vaccines. The drug, JVRS-100, is a so-called "adjuvant," a product that stimulates the immune system to respond more strongly to a vaccine.
San Francisco Business Times
San Francisco Business Times
Upcoming Events
-
21Oct